RNA challenge phages are modified versions of bacteriophage P22 that allow one to select directly for a specific RNA-protein interaction in vivo. The original construction method for generating a bacteriophage that encodes a specific RNA target requires two homologous recombination reactions between plasmids and phages in bacteria. An improved method is described that enables one to readily construct RNA challenge phages through a single homologous recombination reaction in vivo. We have applied the new method to construct a derivative of P22 R17 , an RNA challenge phage that undergoes lysogenic development in bacterial cells that express the bacteriophage R17/MS2 coat protein.
We recently reported an RNA challenge phage system that enables one to genetically select proteins with RNA-binding activity in bacteria (1) . RNA challenge phages are modified versions of bacteriophage P22 in which post-transcriptional regulatory events control the developmental fate of the phage (Fig. 1) . The original method for constructing RNA challenge phages was developed to study the RNA-binding activities for which the RNA sequence and the RNA-binding activity are known (1) . In many systems, however, the molecular identity of the RNA target remains unknown. Challenge phage libraries that encode a population of candidate RNA-binding sites cannot be constructed with current phage methods. In this system, an RNA target site is introduced into the challenge phage through homologous recombination in Salmonella typhimurium. Alleles of the arc gene are used to identify P22 derivatives that contain the desired RNA-binding site (1, 2) . However, the arc(Am) allele that was located on the recipient phage is replaced by an arc + allele for progeny phage acquiring the RNA-binding sequence. To restore the arc(Am) allele to the P22 challenge phage that encodes the RNA-binding site, a second homologous recombination reaction between two P22 bacteriophages in S.typhimurium is required (Fig. 2a) . We now report the design and structure of new reagents that enable RNA challenge phages to be constructed in a single homologous recombination reaction in vivo. The revised recombination substrates swap arc alleles between the donor plasmid and the recipient P22 phage so that all recombinant progeny phages that encode the desired RNA-binding site will contain arc(Am) as shown in Figure 2b . The recombination proficiencies of the new reagents were evaluated by performing homologous recombination reactions in MS1883. Following P22 mnt::Kn9 arc(Am) infection of MS1883 containing either pΦGen1, pPY190 (3) or pMMW20 (1), the progeny phages obtained were assessed for their ability to plaque on MS1582. P22 progeny phages derived from infection of cells * To whom correspondence should be addressed . The DNA sequence that encodes the modified RNA target site was incorporated into pΦGen1 according to standard procedures (4) using a single-stranded phagemid DNA template of pΦGen1 that contained deoxyuridine residues and the following DNA oligonucleotide (Operon Technologies, Inc.): 5′-GGCTTCGGTTGTCAGATCTACAGCATTAGCGTAGAGAGGAACCAACATGAATAG-3′. containing pΦGen1 were able to plaque on MS1582 at frequencies 10-and 20-fold greater than progeny phages obtained from infection of cells containing pPY190 and pMMW20 respectively (Table 1) ; a similar trend is observed when P22 mnt::Kn9 is used as the infecting phage (Table 1 ). These data indicate that the transfer of the O mnt -allele from the respective plasmid to the P22 infecting phage occurs more readily with pΦGen1 than with either pPY190 or pMMW20. The transfer frequency of the arc allele was determined by calculating the ratio of clear plaques to turbid plaques obtained for P22 progeny plated on MS1582. The P22 phages recombined with the arc allele from pΦGen1 at a greater frequency than observed from either pPY190 or pMMW20 ( Table 1 ). The increased recombination frequencies of P22 phages with pΦGen1 may be attributed to the larger region of homologous P22 mnt::Kn9 phage DNA that is present in this plasmid-1.95 kb, in comparison with 0.235 and 0.495 kb regions of homology on pPY190 and pMMW20 respectively. We evaluated the new reagents in RNA challenge phage construction by introducing a modified R17 RNA operator site into the P22 mnt::Kn9 phage as outlined in Figure 2 . PCR/RFLP studies and direct DNA sequence analysis demonstrated that ∼50% of the progeny phages that were obtained from homologous recombination of the P22 mnt::Kn9 phage with plasmid DNA in MS1883 and that formed clear plaques on the MS1582 host contain both the arc(Am) allele and the desired RNA operator site. As expected, all the P22 phage derivatives that encoded the desired RNA operator site also carried the arc(Am) allele.
The RNA operator site that is encoded by P22 R17 [L19] contains an RNA structure that normally should be recognized by the R17/MS2 coat protein because the structural features necessary for efficient coat protein binding are present (1,5) ; however, the ribosome-binding site and the initiator codon of the ant gene are positioned entirely outside this coat protein RNA-binding site (Fig. 2c) . These elements are normally located within the context of the RNA secondary structure recognized by the R17/MS2 coat protein (5) . The bacteriophage P22 R17 , which encodes the wild-type R17/MS2 RNA operator site in the 5′-end of the phage ant gene, forms lysogens in S.typhimurium strains that express the R17/MS2 coat protein (1 (Table 1; ref. 1 ). Thus, one should be able to select for a particular RNA-protein interaction in vivo using the RNA challenge phage system so long as the RNA-protein interaction of interest prevents translation of the ant mRNA.
In summary, we describe new reagents that enable RNA challenge phages to be constructed following a single recombination reaction in vivo. The improved efficiency of the described method makes it feasible to readily construct either RNA challenge phages that encode a well defined RNA-binding site or a phage library containing a population of randomly cloned RNA-binding sites from which the RNA component may be selected for a particular RNA-binding activity.
